Screening of cationic compounds as an absorption enhancer for nasal drug delivery.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  International journal of pharmaceutics

• Publication date

  1999-08-05

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0378-5173(99)00100-3PMID 10425360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High absorbency and subchronic morphologic effects on the nasal epithelium of a nasal insulin powder dosage form with a soybean-derived sterylglucoside mixture in rabbits.

  1998cited by this paper
• Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.

  1998cited by this paper
• N-Trimethyl Chitosan Chloride as a Potential Absorption Enhancer Across Mucosal Surfaces: In Vitro Evaluation in Intestinal Epithelial Cells (Caco-2)

  1997cited by this paper
• Preparation and in vitro characterisation of mucoadhesive polymeric microspheres as intra-nasal delivery systems

  1997cited by this paper
• Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement

  1997cited by this paper
• Confocal Laser Scanning Microscopic Visualization of the Transport of Dextrans After Nasal Administration to Rats: Effects of Absorption Enhancers

  1997cited by this paper
• Chitosan as a nasal delivery system: evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models

  1996cited by this paper
• Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane.

  1996cited by this paper
• Effectiveness and Toxicity Screening of Various Absorption Enhancers in the Rat Small Intestine: Effects of Absorption Enhancers on the Intestinal Absorption of Phenol Red and the Release of Protein and Phospholipids from the Intestinal Membrane

  1996cited by this paper
• Effects of Absorption Enhancers on Rat Nasal Epithelium in Vivo: Release of Marker Compounds in the Nasal Cavity

  1995cited by this paper
• Evaluation of enhancers to increase nasal absorption using Ussing chamber technique.

  1994cited by this paper
• Chitosan as a Novel Nasal Delivery System for Peptide Drugs

  1994cited by this paper
• Cyclodextrins as protection agents against enhancer damage in nasal delivery systems II. Effect on in vivo absorption of insulin and histopathology of nasal membrane

  1994cited by this paper
• Cyclodextrins as protection agents against enhancer damage in nasal delivery systems I. Assessment of effect by measurement of erythrocyte haemolysis

  1994cited by this paper
• In vitro permeation of several model drugs across rabbit nasal mucosa

  1994cited by this paper
• Cationic proteins alter smooth muscle function by an epithelium-dependent mechanism.

  1993cited by this paper
• Absorption enhancers in nasal drug delivery: efficacy and safety

  1993cited by this paper
• Interaction of polycations with cell-surface negative charges of epithelial cells.

  1992cited by this paper
• Effects of Viscous Hyaluronate–Sodium Solutions on the Nasal Absorption of Vasopressin and An Analogue

  1991cited by this paper
• The eosinophil and bronchial asthma: current understanding.

  1990cited by this paper
• Nasal systemic drug delivery

  1989cited by this paper
• Biochemical and amino acid sequence analysis of human eosinophil granule major basic protein.

  1988cited by this paper
• Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity.

  1987cited by this paper
• Effect of surfactants on the nasal absorption of insulin in rats

  1981cited by this paper
• A pharmacokinetic analysis program (multi) for microcomputer.

  1981cited by this paper

• Brain drug delivery from the nasal olfactory region is enhanced using lauroylcholine chloride: An estimation using in vivo PET imaging.

  2024cites this paper
• 鼻腔药物递送的影响因素和提高递送效率的设计策略

  2023cites this paper
• Arginine-Coated Nanoglobules for the Nasal Delivery of Insulin

  2023cites this paper
• Cetylpyridinium chloride blocks herpes simplex virus replication in gingival fibroblasts.

  2020cites this paper
• Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management

  2020cites this paper
• Enhancement Effect of Poly-L-ornithine on the Nasal Absorption of Water-Soluble Macromolecules in Rats.

  2019cites this paper
• The Use of Chitosan, Alginate, and Pectin in the Biomedical and Food Sector—Biocompatibility, Bioadhesiveness, and Biodegradability

  2019cites this paper
• Recent advances in carrier mediated nose‐to‐brain delivery of pharmaceutics

  2018cites this paper
• Improved Intranasal Retentivity and Transnasal Absorption Enhancement by PEGylated Poly-l-ornithine

  2018cites this paper
• Polyarginine nanocapsules: A versatile nanocarrier with potential in transmucosal drug delivery.

  2017cites this paper
• Preparation and Evaluation of PEGylated Poly-L-ornithine Complex as a Novel Absorption Enhancer.

  2017cites this paper
• Nanogel-based nasal vaccines for infectious and lifestyle-related diseases.

  2017cites this paper
• Development of a Transnasal Delivery System for Recombinant Human Growth Hormone (rhGH): Effects of the Concentration and Molecular Weight of Poly-L-arginine on the Nasal Absorption of rhGH in Rats.

  2016cites this paper
• Stearylated cycloarginine nanosystems for intracellular delivery – simulations, formulation and proof of concept

  2016cites this paper
• How to overcome the limitations of current insulin administration with new non-invasive delivery systems.

  2015cites this paper
• Receptor-mediated endocytosis of macromolecules and strategy to enhance their transport in alveolar epithelial cells

  2015cites this paper
• Nasal Drug Delivery Systems: An Overview

  2015cites this paper
• Novel designed polyoxyethylene nonionic surfactant with improved safety and efficiency for anticancer drug delivery

  2014cites this paper
• The Adjuvant Activity and Mechanisms of Action for Mastoparan 7 Peptide After Intranasal Immunization in Mice

  2014cites this paper
• A Mechanism Enhancing Macromolecule Transport Through Paracellular Spaces Induced by Poly-L-Arginine: Poly-L-Arginine Induces the Internalization of Tight Junction Proteins via Clathrin-Mediated Endocytosis

  2014cites this paper
• Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres.

  2014cites this paper
• Effect of poly-L-arginine on intestinal absorption of hydrophilic macromolecules in rats.

  2013cites this paper
• Enhanced Nasal Mucosal Delivery and Immunogenicity of Anti-Caries DNA Vaccine through Incorporation of Anionic Liposomes in Chitosan/DNA Complexes

  2013cites this paper
• Enhancing effect of poly(amino acid)s on albumin uptake in human lung epithelial A549 cells.

  2013cites this paper
• Factores que intervienen en el diseño de sistemas de liberación nasal de péptidos y proteínas

  2013cites this paper
• Nasal Drug Delivery of a Mucoadhesive Oxybutynin Chloride Gel: In Vitro Evaluation and In Vivo in Situ Study in Experimental Rats

  2013cites this paper
• Poly-L-arginine-Induced internalization of tight junction proteins increases the paracellular permeability of the Caco-2 cell monolayer to hydrophilic macromolecules.

  2013cites this paper
• Factors involved in the design of nasal delivery systems for peptides and proteins

  2013cites this paper
• Development of an antimicrobial wound dressing by co-electrospinning bacteriocins of lactic acid bacteria into polymeric nanofibers

  2012cites this paper
• Formulation technologies to overcome unfavorable properties of peptides and proteins for pulmonary delivery.

  2012cites this paper
• In vivo application of chitosan to facilitate intestinal acyclovir absorption in rats.

  2012cites this paper
• Development of sponge-like dressings for mucosal/transmucosal drug delivery into vaginal cavity

  2012cites this paper
• Thermal-sensitive hydrogel as adjuvant-free vaccine delivery system for H5N1 intranasal immunization.

  2012cites this paper
• Enhancement effect of poly(amino acid)s on insulin uptake in alveolar epithelial cells.

  2012cites this paper
• Effect of absorption enhancers on nasal delivery of basic fibroblast growth factor

  2011influential citation
• [Effects of sperminated pullulans on the pulmonary absorption of insulin].

  2011cites this paper
• [Enhancement of insulin absorption through mucosal membranes using cationic polymers].

  2010cites this paper
• Drug Transporter Expression and Localization in Rat Nasal Respiratory and Olfactory Mucosa and Olfactory Bulb

  2010cites this paper
• In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules.

  2010cites this paper
• Delivering Horseradish Peroxidase as a Respirable Powder to the Isolated, Perfused, and Ventilated Lung of the Rat: The Pulmonary Disposition of an Inhaled Model Biopharmaceutical

  2010cites this paper
• Effect of Sperminated Pullulans on Drug Permeation through Isolated Rabbit Cornea and Determination of Ocular Irritation

  2010cites this paper
• New strategies to improve the intranasal absorption of insulin.

  2010cites this paper
• Characterization of novel quaternary chitosan derivative nanoparticles loaded with protein

  2009cites this paper
• Enhanced permeability of the urinary bladder wall: the role of polymer charge.

  2009cites this paper
• Rat nasal lavage biomarkers to assess preclinical irritation potential of nasal drug formulations and excipients.

  2009cites this paper
• Application of the Renkin function to characterize paracellular pathways in the nasal absorption of FITC-dextrans in rats

  2009cites this paper
• Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues.

  2008cites this paper
• Spermined dextran, a cationized polymer, as absorption enhancer for pulmonary application of peptide drugs.

  2008cites this paper
• Cracking the junction: update on the progress of gastrointestinal absorption enhancement in the delivery of poorly absorbed drugs.

  2008cites this paper
• Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans.

  2008cites this paper
• Complexation of a Poly-l-Arginine with Low Molecular Weight Heparin Enhances Pulmonary Absorption of the Drug

  2008influential citation
• Effects of sperminated polymers on the pulmonary absorption of insulin.

  2008cites this paper
• Effects of a sperminated gelatin on the nasal absorption of insulin.

  2007cites this paper
• Ability of poly-L-arginine to enhance drug absorption into aqueous humor and vitreous body after instillation in rabbits.

  2007cites this paper
• In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo.

  2007cites this paper
• Nasal residence of insulin containing lyophilised nasal insert formulations, using gamma scintigraphy.

  2007cites this paper
• Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin.

  2007cites this paper
• Transport Characteristics of a Beta Sheet Breaker Peptide Across Excised Bovine Nasal Mucosa

  2007cites this paper
• Effect of cationized gelatins on the paracellular transport of drugs through caco-2 cell monolayers.

  2006cites this paper
• Permeation enhancers in the transmucosal delivery of macromolecules.

  2006cites this paper
• Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part I. Influence of formulation variables on drug absorption in anesthetized rats.

  2006cites this paper
• Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.

  2006cites this paper
• Effects of poly-L-arginine on the permeation of hydrophilic compounds through surface ocular tissues.

  2006cites this paper
• Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.

  2006cites this paper
• Permeability of pig urinary bladder wall: the effect of chitosan and the role of calcium.

  2005cites this paper
• Pharmacokinetics, toxicity of nasal cilia and immunomodulating effects in Sprague–Dawley rats following intranasal delivery of thymopentin with or without absorption enhancers

  2005cites this paper
• Application of sterylglucoside-containing particles for drug delivery.

  2005cites this paper
• In vivo evaluation of nicotine lyophilised nasal insert in sheep.

  2005cites this paper
• Effect of aminated gelatin on the nasal absorption of insulin in rats.

  2005cites this paper
• Prostaglandin production by human gingival fibroblasts inhibited by triclosan in the presence of cetylpyridinium chloride.

  2005cites this paper
• Nouveaux procedes et nouvelles compositions pour une administration amelioree par voie muqueuse de peptides et de proteines

  2004cites this paper
• Polyarginine Inhibits gp160 Processing by Furin and Suppresses Productive Human Immunodeficiency Virus Type 1 Infection*

  2004cites this paper
• Chitosan as a Delivery System for the Transmucosal Administration of Drugs

  2004cites this paper
• In vitro permeation studies comparing bovine nasal mucosa, porcine cornea and artificial membrane: androstenedione in microemulsions and their components.

  2004cites this paper
• Extended Nasal Residence Time of Lysostaphin and an Anti-Staphylococcal Monoclonal Antibody by Delivery in Semisolid or Polymeric Carriers

  2004cites this paper
• Chitosan chemistry and pharmaceutical perspectives.

  2004cites this paper
• Engineering of Poly (DL-lactic-co-glycolic acid) Nano-composite Particle for Dry Powder Inhalation Dosage Forms of Insulin with Spray Fluidized Bed Granulating System

  2004cites this paper
• Chitosan salts as nasal sustained delivery systems for peptidic drugs

  2003cites this paper
• Absorption Enhancers for Nasal Drug Delivery

  2003cites this paper
• Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.

  2003cites this paper
• Drug Delivery Systems の投与部位としての鼻粘膜の役割

  2003cites this paper
• Poly-l-Arginine Enhances Paracellular Permeability via Serine/Threonine Phosphorylation of ZO-1 and Tyrosine Dephosphorylation of Occludin in Rabbit Nasal Epithelium

  2003cites this paper
• Einfluss von Formulierungsparametern auf die nasale Verfügbarkeit von Natriumcromoglicat, Xylometazolinhydrochlorid und Oxymetazolinhydrochlorid

  2003cites this paper
• Correlation of SEC/MALLS with ultracentrifuge and viscometric data for chitosans

  2003cites this paper
• Poly-L-Arginine Predominantly Increases the Paracellular Permeability of Hydrophilic Macromolecules Across Rabbit Nasal Epithelium in Vitro

  2003cites this paper
• Chitin and Chitosan from Animal Sources

  2002cites this paper
• Nasal drug delivery: new developments and strategies.

  2002cites this paper
• Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats

  2002influential citation
• Analysis of transient and reversible effects of poly-L-arginine on the in vivo nasal absorption of FITC-dextran in rats.

  2002cites this paper
• Improved nasal absorption of drugs using poly-L-arginine: effects of concentration and molecular weight of poly-L-arginine on the nasal absorption of fluorescein isothiocyanate-dextran in rats.

  2001cites this paper
• Intranasal vaccination against plague, tetanus and diphtheria.

  2001cites this paper
• Lantibiotics as surface active agents for biomedical applications

  2001cites this paper
• Effect of poly-L-arginine on the nasal absorption of FITC-dextran of different molecular weights and recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats.

  2001cites this paper
• ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid.

  2001cites this paper
• Synthetic biomimetic supra molecular Biovector (SMBV) particles for nasal vaccine delivery.

  2001cites this paper
• Synthetic biomimetic supra molecular Biovector (SMBV) particles for nasal vaccine delivery.

  2001cites this paper
• Regional variation in oral mucosal drug permeability.

  2000cites this paper